Key terms

About TEVA

Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: North America, Europe, and International Markets. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest TEVA news

Apr 11 1:36pm ET Pfizer (NYSE:PFE) Settlement Sends Shares Up Slightly by TipRanks Apr 11 8:41am ET Teva announces AJOVY study met all critical efficacy endpoints in China trial by TipRanks Apr 07 6:31am ET Teva presents eight studies from LAI schizophrenia research program by TipRanks Apr 05 3:25am ET Barclays Reaffirms Their Buy Rating on Teva Pharmaceutical (TEVA) by TipRanks Apr 04 3:36pm ET Teva put volume heavy and directionally bearish by TipRanks Apr 04 8:39am ET Teva Pharmaceuticals, mAbxience announce strategic global agreement by TipRanks Apr 01 8:33am ET Teva, Launch Therapeutics enter clinical collaboration agreement by TipRanks Mar 08 9:40am ET GE upgraded, Vail Resorts downgraded: Wall Street’s top analyst calls by TipRanks Mar 08 7:10am ET Teva upgraded to Neutral from Underweight at JPMorgan by TipRanks Mar 04 9:27am ET UBS confident in Teva’s continued growth trajectory by TipRanks Feb 26 7:55am ET Piper Sandler Sticks to Its Buy Rating for Teva Pharmaceutical (TEVA) by TipRanks Feb 26 7:12am ET Teva, Jiangsu Nhwa Pharmaceutical enter partnership by TipRanks Feb 25 6:23am ET Alvotech, Teva announce U.S. approval of SIMLANDI injection by TipRanks Feb 20 10:35am ET Teva put volume heavy and directionally bearish by TipRanks Feb 20 9:09am ET Teva presents data confirming target engagement o TEV-‘574 at ECCO meeting by TipRanks Feb 13 1:00am ET Teva Pharmaceutical Industries Limited Is Worried About This – Should You Be Worried Too? by TipRanks Feb 12 9:47am ET Teva rises 5.2% by TipRanks Feb 12 5:04am ET Teva upgraded to Overweight from Neutral at Piper Sandler by TipRanks Feb 12 5:02am ET Analysts Offer Insights on Healthcare Companies: India Globalization Capital (IGC), Tango Therapeutics (TNGX) and Teva Pharmaceutical (TEVA) by TipRanks Feb 05 7:30am ET Analysts Offer Insights on Healthcare Companies: Siemens Healthineers AG (OtherSEMHF), Teva Pharmaceutical (TEVA) and ACADIA Pharmaceuticals (ACAD) by TipRanks Feb 05 5:46am ET Teva price target raised to $17 from $15 at Barclays by TipRanks Feb 05 2:56am ET Barclays Sticks to Its Buy Rating for Teva Pharmaceutical (TEVA) by TipRanks Feb 05 12:05am ET Goldman Sachs Sticks to Its Hold Rating for Teva Pharmaceutical (TEVA) by TipRanks Feb 01 7:39am ET Teva price target raised to $16 from $15 at UBS by TipRanks Feb 01 4:25am ET UBS Remains a Buy on Teva Pharmaceutical (TEVA) by TipRanks Jan 31 8:58am ET Teva expects ‘stabilization’ of generics business in North America in 2024 by TipRanks Jan 31 8:29am ET Teva (NYSE:TEVA) Delivers Q4 Beat; To Divest API Unit by TipRanks Jan 31 8:27am ET Teva expects 2H24 revenue ‘slightly higher’ than 1H24 by TipRanks Jan 31 8:12am ET Teva expects Austedo to achieve $2.5B in sales by 2027 by TipRanks Jan 31 7:15am ET Teva sees FY24 EPS $2.20-$2.50, consensus $2.42 by TipRanks Jan 31 7:11am ET Teva reports Q4 EPS $1.00, consensus 77c by TipRanks
Apr 08 5:06am ET Forget Nvidia: 3 Prominent Billionaire Investors Are Selling It and Buying These 6 Value Stocks Instead by Motley Fool Apr 03 5:21am ET 3 No-Brainer Stocks to Buy With $600 Right Now by Motley Fool

No recent press releases are available for TEVA

TEVA Financials

1-year income & revenue

Key terms

TEVA Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

TEVA Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

Tim Wren, chief commercial officer for BSI Group, right, presents Kristalina Georgieva, chief executive officer of the World Bank Group, second right, with ISO 20121 certification for sustainable event management at an event during the spring meetings of the International Monetary Fund (IMF) and World Bank in Washington, DC, US, on Monday, April 15, 2024. The IMF and World Bank spring meetings in Washington are expected to draw thousands of delegates, observers and journalists from the fund's 190 member countries. Photographer: Samuel Corum/Bloomberg via Getty Images
Samuel Corum/Bloomberg/Getty Images
Geopolitical strife is roiling Wall Street. Here’s what investors are watching
Donald Trump might no longer own a majority of TMTG after a new public share offering.
Joe Raedle/Getty Images
Trump stock tanks after announcing massive share sale
1040 US Individual Income Tax Return Form
Nora Carol Photography/Moment RF/Getty Images
Three ways investors can minimize their tax payments
People walk past the New York Stock Exchange (NYSE) on April 10, 2024 in New York City.
Spencer Platt/Getty Images
Dow closes nearly 500 points lower on fears of potential Iranian attack on Israel